Stocktoria
DiaSorin S.p.A. DIA.MI
IT · Borsa Italiana · XMIL · stock · Healthcare · website
DiaSorin S.p.A. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €1.2B | €1.2B | €1.1B | €1.4B |
| Gross profit | €773.5M | €781.7M | €741.2M | €900.6M |
| R&D expense | €95.0M | €91.6M | €90.9M | €96.9M |
| SG&A expense | €364.2M | €376.1M | €368.1M | €364.8M |
| Operating income | €269.6M | €265.0M | €237.8M | €375.3M |
| Interest expense | €24.5M | €27.6M | €29.3M | €34.6M |
| Income tax | €61.6M | €55.4M | €42.7M | €85.8M |
| Net income | €155.6M | €188.1M | €159.8M | €240.9M |
| EPS (diluted) | €2.83 | €3.47 | €2.87 | €4.15 |
| Operating cash flow | €342.8M | €358.8M | €311.7M | €389.3M |
| Free cash flow | €205.1M | €239.1M | €198.4M | €275.7M |
| Cash & equivalents | €165.8M | €344.3M | €280.3M | €241.8M |
| Inventory | €334.6M | €344.0M | €315.5M | €306.5M |
| Goodwill | €754.2M | €846.9M | €799.4M | €826.4M |
| Total assets | €2.9B | €3.3B | €3.2B | €3.4B |
| Total debt | €791.2M | €1.0B | €1.2B | €1.4B |
| Total liabilities | €1.3B | €1.5B | €1.7B | €1.9B |
| Shareholders' equity | €1.6B | €1.8B | €1.5B | €1.5B |
Growth · year-over-year · Revenue CAGR -4.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +0.8% | +3.2% | -15.6% | — |
| Net income growth | -17.3% | +17.7% | -33.6% | — |
| EPS growth | -18.4% | +20.9% | -30.8% | — |
| Free cash flow growth | -14.2% | +20.5% | -28.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · IT · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.